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Despite their distinct targets, all addictive drugs commonly abused by humans evoke
increases in dopamine (DA) concentration within the striatum. The main DA Guanine
nucleotide binding protein couple receptors (GPCRs) expressed by medium-sized spiny
neurons of the striatum are the D1R and D2R, which are positively and negatively coupled
to cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling, respectively.
These two DA GPCRs are largely segregated into distinct neuronal populations, where
they are co-expressed with glutamate receptors in dendritic spines. Direct and indirect
interactions between DA GPCRs and glutamate receptors are the molecular basis by
which DA modulates glutamate transmission and controls striatal plasticity and behavior
induced by drugs of abuse. A major downstream target of striatal D1R is the extracellular
signal-regulated kinase (ERK) kinase pathway. ERK activation by drugs of abuse behaves
as a key integrator of D1R and glutamate NMDAR signaling. Once activated, ERK can
trigger chromatin remodeling and induce gene expression that permits long-term cellular
alterations and drug-induced morphological and behavioral changes. Besides the classical
cAMP/PKA pathway, downstreamof D1R, recent evidence implicates a cAMP-independent
crosstalk mechanism by which the D1R potentiates NMDAR-mediated calcium inﬂux and
ERK activation. The mounting evidence of reciprocal modulation of DA and glutamate
receptors adds further intricacy to striatal synaptic signaling and is liable to prove relevant for
addictive drug-induced signaling, plasticity, and behavior. Herein, we review the evidence
that built our understanding of the consequences of this synergistic signaling for the actions
of drugs of abuse.
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INTRODUCTION
Drug addiction can be considered as a chronic and relapsing
psychiatric disorder induced by repeated pharmacological manip-
ulation of the so-called mesolimbic reward circuitry by drugs
of abuse. It can be viewed as maladaptive neural plasticity that
occurs in vulnerable individuals in response to repeated exposure
to drugs. Thus, addictive drugs change brain properties that nor-
mally permit us to adapt to environmental stimuli (Kelley, 2004;
Everitt and Robbins, 2005). By changing motivational circuitry,
addictive drugs progressively orient behavior toward drug-seeking
and drug-taking strategies that are life-long behavioral changes
(Hyman et al., 2006). The persistence of these behavioral changes
relies on alterations in gene expression, an important mech-
anism by which chronic exposure to a drug of abuse elicits
long-lasting plasticity in the brain. All drugs of abuse enhance
extracellular dopamine (DA) levels in the forebrain, especially in
the ventral part of the striatum, the nucleus accumbens (NAcc;
Di Chiara and Imperato, 1988), where they control transcrip-
tion and new protein synthesis (Robinson and Nestler, 2011)
within medium-sized spiny neurons (MSNs), the major striatal
neuron population. These DA inputs are normally activated in
response to unpredicted rewards (Schultz, 2010), and control
glutamatergic striatal inputs that are informative of the context.
By hijacking DA release, drugs of abuse drive cortico-striatal plas-
ticity (Wickens, 2009). The search for therapeutic targets to treat
addiction has been recently encouraged by the discovery of new
cellular and molecular substrates of DA-driven signaling in the
striatum.
The main DA GPCRs expressed by MSNs of the striatum
are the D1R and D2R, which are positively and negatively cou-
pled to cyclic adenosine monophosphate (cAMP)/protein kinase
A (PKA) signaling, respectively. However, besides these classical
signaling pathways, it now becomes evident that direct and indi-
rect interactions between DA-R and glutamate receptors are the
molecular basis by which DA controls striatal plasticity and behav-
ior induced by drugs of abuse. The extracellular signal-regulated
kinase (ERK) signaling pathway, which is activated in a DA-D1R
and NMDAR dependent manner in MSNs in response to drugs
of abuse, forms the central core of striatal plasticity and adap-
tive behaviors in response to these drugs (Girault et al., 2007).
We review herein evidence from the literature indicating that
D1R-glutamate convergence onto ERK signaling in the striatum
is a critical event onto striatal plasticity in response to drugs of
abuse.
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STRIATAL MSN AT THE JUNCTION OF DA AND GLUTAMATE
TRANSMISSION
THE DA AND GLUTAMATE HYPOTHESES OF ADDICTION
Despite their different principal targets of action, common drugs
of abuse have a shared secondary consequence onDA transmission
(Di Chiara and Imperato, 1988). Dialysis for extracellular levels
of DA in the striatum revealed large increases from basal levels
by administration of drugs abused by humans including cocaine,
amphetamine, and morphine. This increase in DA levels is signif-
icantly higher in the ventral region, NAcc, than in the dorsal part.
Both regions receive dense DA afferents from the ventral tegmen-
tal area (VTA). In a physiological context, DA transmission in the
striatum inﬂuences motor control, decision making, attention and
working memory, and learning of reward associated stimuli (Rob-
bins and Everitt, 2002). Therefore, it is believed to be involved in
disorders where these processes are perturbed such as Parkinson’s
disease (PD), Huntington’s disease, attention deﬁcit hyperactivity
disorder (ADHD), schizophrenia, Tourette’s syndrome as well as
addiction. The DA hypothesis of addiction has gained signiﬁcant
support but the precise role of DA in reward anticipation and
motivation is still under intense investigation (Wise and Bozarth,
1987). DA transmission is not believed to register the context of
the drug experience, rather it is an associative learning performed
by cortical and subcortical glutamatergic innervations to the stria-
tum, which supports this (Hyman et al., 2006). While an acute
treatment with drugs such as cocaine does not drastically alter the
concentration of glutamate liberated in the striatum, the repeated
administration or self-administration of drugs results in a potenti-
ated glutamate availability at the synapse (Pierce et al., 1996; Zhang
et al., 2001). This loss of control of glutamate transmission has
been proposed to underlie the shift in behavioral control that is
seen after repeated drug treatment (Kalivas, 2009). Importantly
these two important transmission systems engaged by drugs of
abuse, namely DA and glutamate, converge anatomically in the
striatum.
MEDIUM-SIZED SPINY NEURONS INTEGRATE DA AND GLUTAMATE
SIGNALS
The DA and glutamatergic inputs converge onto the dendrites
of the major cell type of the striatum, the MSN. The GABAer-
gic MSNs are generally divided into two groups, based in part
on their expression of either the DA D1 receptor (the D1R) or
the D2 receptor (D2R; Gerfen et al., 1990). Each MSN population
controls the striatal inhibitory output to different basal ganglia
structures forming the direct, D1 expressing, and indirect, D2
expressing, striatal projection pathways and are both acted on by
exposure to drugs of abuse (Smith et al., 2013). The MSN of the
direct pathway inhibit the substantia nigra reticulata (SNr) neu-
rons, which are GABAneurons with high basal ﬁring rate. The
MSNs of the indirect pathway have an opposite effect because
of their inhibitory link formed by projections to the external
globus pallidus (GPe; GABergic), which in turn projects to the
subthalamic nucleus (STN; Glutamatergic). Therefore the indi-
rect pathway leads to the desinhibition of SNr. Activation of
the direct striatonigral pathway desinhibits thalamocortical neu-
rons. The indirect pathway has the opposite effect. DA reinforces
the direct pathway and inhibits the indirect pathway, leading
to harmonious functions of the basal ganglia. Recent evidence,
using genetically encoded calcium sensors, has conﬁrmed original
assumptions that a balance exists between the direct and indirect
pathway and that generation of movements requires the initia-
tion and selection of wanted motor behaviors (Carlezon et al.,
1998; Cui et al., 2013). This is supported by studies where either
population were artiﬁcially activated using light activated Chan-
nel rodopsin. Impressively, when the direct pathway was activated
in this manner the mice produced more ambulation in an open
ﬁeld and, accordingly, the activation of the indirect pathway lead
to an inhibition of movement (Kravitz et al., 2010). Both path-
ways are acted on by DA, and while a combinatorial effect is
undoubtedly central for the actions of drugs of abuse many stud-
ies have highlighted the antagonist relationship between them
(recently reviewed Lobo and Nestler, 2011). In general terms, the
activation of the D1R expressing MSNs promotes initiation of
motor behaviors along with drug reward and sensitizing proper-
ties, while the D2R seem to exert an inhibitory inﬂuence on these
behaviors.
STRIATAL DA RECEPTORS
Dopamine transmission is detected by Guanine nucleotide bind-
ing protein couple receptors (GPCRs), also known as seven-
transmembrane receptors. These are metabotropic receptors share
features such as the interaction with G-proteins, from which
they gain their name, and the seven alpha-helices transmembrane
domain structure that are interconnected by alternating intracel-
lular and extracellular loops. The heterotrimeric G-proteins are
formed by a combination of an α-subunit and βγ dimer, that can
each lead to activation of signaling effectors. Exactly how the DA
receptors couple to the G-proteins is not yet fully understood, but
two models have been proposed (Lohse et al., 2008).
The striatum contains all the subtypes of DA GPCR to different
extents (Missale et al., 1998). Since the late 1970s the DA recep-
tors have been subdivided into two families, originally based on
the prediction that one family is positively coupled to adenylyl
cyclase via Gs proteins and cAMP production, and the other to
its inhibition via Gi proteins (Kebabian and Calne, 1979). After
the identiﬁcation of D1 and D2 receptors came the molecular
cloning and the subsequent discovery of a D3, D4, and D5 (pre-
viously known as the D1b in the rat). The D1R, D2R (Le Moine
and Bloch, 1995), and D5R (Rivera et al., 2002) are expressed both
in the dorsal and ventral striatum, while the D3 is preferentially
expressed in the ventral striatum (Lévesque et al., 1992). The D4R,
relatively speaking, is not as strongly expressed but is detectable in
the striatum (Ariano et al., 1997).
Focus on striatal D1R: regulation by drugs of abuse
As already stated, there is a segregation of D1R andD2R expression
in the two populations of MSNs. These two founding mem-
bers of the DA receptor family are GPCR that are distinguished
on the basis of their coupling to cAMP production and PKA-
mediated signaling (Neve et al., 2004). Although a population of
MSN exists that co-express D1R and D2R, the exact percentage
seems to depend on the method of analysis, however, estimates are
in the region of 17% in the ventral striatum (Bertran-Gonzalez
et al., 2008). Accumulated evidence suggests that from the ﬁrst
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drug exposure, essential signaling, and transcriptional events nec-
essary for drug-induced alterations in behavior are set in motion
primarily in D1R+MSN of the “direct” or striato-nigral, pathway
(Valjent et al., 2000; Bertran-Gonzalez et al., 2008).
The D1R is expressed in the major brain regions of the rein-
forcement learning circuitry (i.e., the cerebral cortex, limbic
system, thalamus) and within the striatum it is strongly expressed
in both dorsal and ventral regions. At the cellular level, the
D1R localizes principally along the perisynaptic neck regions
of dendritic spines (Huang et al., 1992). A similar conclusion
was drawn from immunohistochemical analysis of cortical tis-
sue from humans and primates where the D1R signal was more
“extrasynaptic” (Smiley et al., 1994). In striatal spines, the D1R
come into close proximity with the glutamate receptors at the post
synaptic density (PSD), and they are extensively interconnected
via scaffold proteins and intracellular signaling proteins.
Pre-treatment with SCH23390, a D1R antagonist, inhib-
ited acute cocaine-induced locomotor activity and prevented the
development of locomotor sensitization in a “one-shot” protocol
(Fontana et al., 1993; White et al., 1998). Later studies conﬁrmed
that SCH23390 but not D2R antagonist raclopride, prevented the
development of locomotor sensitization to cocaine, and further-
more a contribution of theNMDAR to this behavior was identiﬁed
(Valjent et al., 2000).
Two lines of D1R KO mice lacked the acute locomotor and
stereotyped behaviors normally induced by cocaine (Xu et al.,
1994; Miner et al., 1995). This altered response was speciﬁc to
D1R homozygous knockout mice since heterozygous mice still
responded (Miner et al., 1995). In a further study, the chronic
effects of cocaine were also perturbed, as the animals did not
show sensitization of the locomotor activity after repeated cocaine
administration (Xu et al., 2000). However, the D1R KO have hyper
basal-locomotor activity, which remained elevated in these studies,
so the use of a locomotor readout for cocaine’s effects may not be
as relevant as other measures. Although D1R KO mice developed
a normal conditioned place preference (CPP) to cocaine (Miner
et al., 1995), they did not develop self-administration of cocaine,
despite having learned sufﬁciently the operant association for food
(Caine et al., 2007). The D1R contribution to self-administration
therefore appeared to be function of the reward and whether con-
text or operant reward learning is recruited relied differentially on
functional D1R.
STRIATAL GLUTAMATE RECEPTORS
The striatum receives vast glutamatergic inputs from cortical
and subcortical regions, which converge anatomically with the
DA inputs. Early studies used various antagonists of glutamate
receptors to show role for glutamate in the development of
drug-induced behaviors (Karler et al., 1989), and lesion studies
conﬁrmed this contribution came from the glutamate circuitry
coming from hippocampus, the PFC, and amygdala onto the NAc
(for review, Wolf, 1998). In MSNs, ionotropic and metabotrophic
glutamate receptors are expressed in close proximity to the
DA GPCR (Hara and Pickel, 2005). This morphological co-
localization of DA and glutamate receptors provides a number
of possibilities for interactions, including signaling crosstalk and
direct interaction in protein complexes.
Metabotropic glutamate receptors
Glutamate, like DA, can also activate GPCRs. Eight mGluRs are
classiﬁed into three groups based on sequence homology and
G protein interactions: group I (mGluR1, mGluR5), group II
(mGluR2, mGluR3), and group III (mGluR4, mGluR6, mGluR7,
and mGluR8; Ferraguti and Shigemoto, 2006).
mGluR1 and mGluR5, which are Gq protein-coupled, are
mostly located postsynaptically (Mitrano and Smith, 2007).
Their activation induces mobilization of intracellular Ca2+ stores
and activation of phospholipase C (Schoepp and Conn, 1993).
mGluR5 KO animals do not self-administer cocaine and do not
display locomotor sensitization (Chiamulera et al., 2001). Sys-
temic administration of the mGluR5 receptor antagonist, MPEP,
decreased cocaine self-administration (Kenny et al., 2003, 2005;
Lee et al., 2005; Platt et al., 2008) and attenuated the ability
of a priming injection of cocaine (Lee et al., 2005) or cocaine-
associated cues (Bäckström and Hyytiä, 2007) to reinstate cocaine
seeking. Administration of MPEP into the NAcc shell attenuated
cocaine priming-induced reinstatement of drug seeking, an ani-
mal model of relapse (Kumaresan et al., 2009). Altogether these
data clearly indicated that activation of mGluR5, speciﬁcally in
the NAcc, may promote the reinstatement of drug seeking.
The activation of the presynaptic Group II mGluRs inhibits
cAMP and PKA signaling as they are coupled to Gi/o pro-
teins. The reduction in extrasynaptic glutamate availability after
chronic cocaine treatment and withdrawal, due to disruption of
the cysteine-glutamate exchanger, removes the tonic activation of
group 2 mGluR that would normally inhibit glutamate release.
This can explain why during reinstatement, the challenge, or
renewed drug experience or cue evokes a potentiated glutamate
response, which is not seen with an acute injection of cocaine
(Pierce et al., 1996).
The group 3 mGluR contain mGluR4, mGluR6, mGluR7, and
mGluR8 and similarly to Group 2 they are negatively coupled
to adenyl cyclase activity and found presynaptically in the gluta-
matergic terminals of the striatum. When an agonist (L-AP4) of
the group 3 mGluR was administered into the striatum of cocaine-
naïve mice there was no effect on locomotor activity, however, in
mice subsequently treated with cocaine the compound was able to
prevent the induction of locomotor sensitization (Mao and Wang,
2000).
Focus on NMDAR: regulation by drugs of abuse
The ionotropic glutamate receptors are classed based on their
afﬁnity for synthetic agonists: N-methyl-D-aspartate (NMDA),
α-amino-3-hydroxy-5-methy-4-isoxazole propionate (AMPA),
and kainate. These are ligand gated ion channels, composed of het-
eromeric complexes of four integral membrane protein subunits
and have long intracellular cytoplasmic tails. Unlike the AMPAR
or kainate receptors, the NMDAR channel is blocked by the pres-
ence of a magnesium ion in a voltage-dependent manner. In this
way they respond to the binding of glutamate only when accom-
panied by a depolarization of the post synaptic membrane (Mayer
et al., 1984). Furthermore their activation requires the binding of
a co-agonist (Kleckner and Dingledine, 1988). The NMDAR are
permeable to monovalent cations and calcium, and so provide
a major entry point for triggering Ca2+dependent intracellular
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pathways. The NMDAR subunits are grouped into classes: GluN1,
GluN2A-D, and GluN3A-B (formally denoted NR1, etc.). The dif-
ferent subunits contain different agonist binding sites, which infer
them each with a speciﬁc pharmacology. The GluN1 or GluN3
are obligatory to form the ion channel and contain the binding
site for the co-agonists glycine (Kleckner and Dingledine, 1988)
or D-serine (Mothet et al., 2000) and it is the GluN2 subunits that
contain the site for glutamate (Laube et al., 1997).
Context-dependent sensitization induced by single exposure
to cocaine is completely prevented in mice pre-treated with
the selective NMDAR antagonist, MK801, in a two-injection
protocol (Valjent et al., 2010), as well as in the repeated injec-
tion protocol (Schenk et al., 1993). Similarly, GluN1-knockdown
mice showed an attenuation of sensitization induced by cocaine
(Ramsey et al., 2008). The precise location at which NMDA recep-
tors are critical appears not tobe limited toDAneurons themselves.
Mice with speciﬁc inactivation of GluN1 in DA neurons did
not show alteration of short-term sensitization, but a decreased
long-term sensitization (Engblom et al., 2008; Zweifel et al., 2008).
In contrast, expression of mutant NMDARs in D1R-containing
MSNs prevented cocaine sensitization (Heusner and Palmiter,
2005). Altogether, these observations support the hypothesis that
NMDARs located in MSNs, in the striatum, and/or on their
terminals in the VTA, as indicated by the effects of local infu-
sion of antagonists (Vezina and Queen, 2000), contribute to the
development of sensitization.
One day after acute cocaine treatment the total expression levels
of theNMDAR subunits do not change in theNAcc, however, their
subcellular localization is altered,with an increased internalization
(Schumann and Yaka, 2009). After a 3-weeks withdrawal from
repeated cocaine exposure, global expression levels and surface
expression of the NMDAR subunits are increased, speciﬁcally in
the NAcc. This indicates that during withdrawal some long-term
processes are occurring to heighten the glutamatergic receptor
levels in the NAcc.
SIGNALING CROSSTALK BETWEEN D1R AND GLUTAMATE
RECEPTORS
D1R-MEDIATED PKA REGULATION AND ITS INFLUENCE ON GLUTAMATE
RECEPTORS
An acute injection of cocaine does not increase the levels of
D1R protein in the dorsal striatum but trigger intracellular sig-
naling cascades that are capable of modulating cell excitability
via interactions with ion channels, including the glutamatergic
AMPAR and NMDAR. In the striatum, as the D1-like family of DA
receptors are coupled to stimulatory Gαsolf G-proteins (see Hervé,
2011, for review), the most widely studied consequence of G-
protein activation downstream of DA receptors is their inﬂuence
on PKA-regulated signaling.
After the binding of DA to D1R a change in G-protein asso-
ciation enables the activation of the Ca2+-insensitive adenylyl
cyclase 5 (AC5) isoform. The major target of cAMP is the
cAMP-dependent PKA that has many targets including the glu-
tamate receptor subunits. The duration of PKA activation is
determined by feedback loops due to the activation of phosphodi-
esterases (PDEs) that are expressed in the striatum and limit cAMP
production (Menniti et al., 2006).
Protein kinase A rapidly phosphorylates the NMDAR (Leonard
andHell, 1997) in response toDA,even after just 30 s in presence of
a DAT inhibitor (Snyder et al., 1998). This phosphorylation occurs
at Ser897of the GluN1 subunit (Tingley et al., 1997). Phosphory-
lation of NMDAR subunits is a well-characterized mechanism to
control their trafﬁcking to the membrane (Scott et al., 2001; Lau
and Zukin, 2007). Ion channels are also targeted by PKA and their
phosphorylation can alter the conductance state of the cell. PKA
mediated phosphorylation of sodium channels leads to hyper-
polarization of MSNs (Schiffmann et al., 1995), and can indirectly
diminishN andP/Q-type channel calcium currents that are largely
localized to dendrites. On the other hand, L-type currents, at the
soma, are potentiated by a PKA mechanism that boosts cellu-
lar conductance (Surmeier et al., 1995). Antagonists of the L-type
Ca2+ channels can prevent the reinstatement of cocaine seeking,
this was linked to the activation of Ca2+/CaM-dependent kinase
CaMKII and regulation of AMPAR trafﬁcking (Anderson et al.,
2008).
PKA REGULATION OF DARPP-32 AND INFLUENCE ON GLUTAMATE
RECEPTORS
A number of the intermediates between PKA and its transmem-
brane protein targets are kinases and/or phosphatases particularly
enriched in the striatum. In the late 80s, the Greengard group
characterized many of these, includingARPP-16 (cAMP-regulated
phoshphoprotein of Mr 16), ARPP-19, ARPP-21 (regulator of
calmodulin signaling), ARPP-39, and ARPP-90 (Rap1Gap,Walaas
et al., 1989; Girault et al., 1990; Walaas and Greengard, 1993).
ARPP-16 and ARPP-19 phosphorylation was conﬁrmed to be
strictly dependent on the D1R (Dulubova et al., 2001). DA and
cAMP regulated phosphoprotein of Mr 32kDa (DARPP-32) was
identiﬁed before many of the ARPPs and has received more atten-
tion in the context of drugs of abuse as the expressionof DARPP-32
is most evident in neurons of the ventral and dorsal striatum
(Walaas et al., 1983).
In the context of addiction, the knockout mice for DARPP-32
had diminished hyper-locomotor responses at low doses of acute
cocaine (Fienberg et al., 1998; Hiroi et al., 1999). Locomotor sen-
sitization to cocaine was absent in the DARPP-32 knockout when
a two injection protocol of sensitization (TIPS) was used (Valjent
et al., 2005) but not after repeated injections (Hiroi et al., 1999).
PKA phosphorylates the Thr34 residue of DARPP-32 that permits
it to act as an inhibitor of protein phosphatase I (PP1, Hemmings
et al., 1984). By this means, DARPP-32 supports PKA driven activ-
ity, in particular certain substrates such as the phosphorylation of
GluR1 at Ser845 and GluN1 at Ser897. Additional phosphorylation
sites regulate DARPP-32 activity including Thr75 by Cdk5, Ser97
by CK2, and Ser130by CK1 (see Walaas et al., 2011, for review).
The Thr75 phosphorylation allows DARPP-32 to regulate its own
activity by inhibiting PKA and, in basal conditions this site is
phosphorylated. The Ser97 site is located near a nuclear export
signal and aids DARPP-32 to remain outside the nucleus when
phosphorylated (Stipanovich et al., 2008). The Ser130residue also
allows DARPP-32 to regulate its own activity because it inhibits
the dephosphorylation of the Thr75 site by protein phosphatase
2B (PP2B). The gene encoding DARPP-32, ppp1r1b, is subject
to polymorphisms in humans that gives rise to a truncated form
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(t-DARPP-32), which lacks the Thr75 site and is associated with
schizophrenic and bipolar phenotypes (Kunii et al., 2013). These
sites are equally subject to dephosphorylation. Thr34 is dephos-
phorylated by the CaN and thereby allows the activity of PP1
(Nishi et al., 1999). On the other hand, dephosphorylation of
Thr75 by PP2A, favors the phosphorylation of Thr34 and PP1
inhibition. PP2A also dephosphorylates the Ser97 residue. In the
striatum, PP2A is activated after cAMP-induced phosphorylation
of its B56δ subunit.
One extensive study systematically assessed the role of the dif-
ferent residues in DARPP-32 by performing point mutations that
replaced the sites that would be normally be phosphorylated by
an alanine (Stipanovich et al., 2008). A notable effect was that
the Ser97 site in itself controls the subcellular localization of
DARPP-32. When Ser97was mutated to alanine, DARPP-32 was
unable to be exported from the nucleus to the cytoplasm and
the opposite was observed if a phosphorylation-mimicking muta-
tion, to aspartate, was made. Both these effects were preserved
even after activation of the D1R by SKF81297. To investigate
the Ser97 mutation to alanine in vivo, mutant mice were also
generated and analyzed for alterations in cocaine-induced behav-
iors (Stipanovich et al., 2008). Firstly, the Ser97Ala-DARPP32
mice had normal acute locomotor responses to cocaine but a
reduced locomotor sensitization to a second cocaine injection.
Secondly, cocaine-induced CPP was not observed in these mice.
Finally, this mouse line had a lower breaking point in a food
self-administration test. These ﬁndings suggested that the nuclear
shuttling of DARPP-32 is particularly important for the learned
associative behaviors for reward seeking. The contribution of
DARPP-32 in locomotor behaviors was further investigated in
conditional knockout mice for DARPP-32 expression in either the
D1R-expressing or D2R-expressing MSNs (Bateup et al., 2010).
The loss of DARPP-32 in either population prevented the induc-
tion of long term potentiation (LTP). The conditional knockout in
D1RMSNs had a diminished basal locomotor activity asmeasured
by the distance traveled in an open ﬁeld maze, while a dis-
inhibition of activity was seen in the D2R conditional knockout.
The lack of effect on basal locomotion in the full knockout may
be interpreted as the net result of this D1R-MSN hypo-locomotor
activity plus the D2R-MSN driven hyperactivity.
D1R MODULATION OF NMDAR SIGNALING VIA SFK
When Wittman and colleagues investigated the potentiation of
NMDAR responses by clozapine (a last-resort medication for
schizophrenia which has multiple actions including on the DA
and Glu limbic system), they found that PKA inhibitors prevented
the D1R enhancement of NMDAR transmission. Similar results
were also found in presence of “PP2,” an inhibitor of the Src family
kinases (SFKs). They went on to show that the D1R stimulation
potentiated calcium inﬂux via NMDAR containing the GluN2B
subunit (Wittmann et al., 2005). The SFK members expressed
in the CNS are Src itself, Fyn, Lyn, Lck, and Yes. Src and Fyn
are the most homologous in sequence and are both found in the
PSD, where they potentiate NMDAR currents (Köhr and Seeburg,
1996).
Using subcellular fractionation, Dunah and Standaert (2001)
observed that the GluN2B and GluN2A contents of synaptosomal
striatal membranes were increased after stimulation of the D1R
and this was dependent on the action of protein tyrosine kinases.
GluN2B can be phosphorylated by SFK/Fyn in vivo (Nakazawa
et al., 2001), and D1R-induced enhancement in the synaptic con-
tent of NMDAR subunits is absent in Fyn knockout mice (Dunah
et al., 2004). Yaka et al. (2002) noticed sequence homology between
certain regions in Fyn and GluN2B-ct and described a bind-
ing interaction between these two sites with the scaffold protein
RACK1 that limits the ability of Fyn to phosphorylate GluN2B.
In a follow up study, the authors further characterized the impli-
cated pathways and found that, in the hippocampus, activation of
the pituitary adenylate cyclase activating peptide (PACAP) recep-
tors stimulated Gs signaling that releases RACK1 from GluN2B
and Fyn and increased NMDAR activity. This was associated with
PACAP-induced translocation of RACK1 to the nucleus where
it induced brain derived neurotrophic factor (BDNF) expression
(Yaka et al., 2003). An interaction also exists between Fyn and
PSD-95, since the Src homology 2 (SH2) domain of Fyn binds to
the third PDZ domain of PSD-95 (Tezuka et al., 1999). PSD-95
associates with the last four amino acids of the GluN2B subunit,
which are in close proximity to the Tyr1472 residues targeted by
Fyn. In this way, PSD-95 may bring Fyn nearer to the GluN2B sub-
unit for its phosphorylation and also regulate GluN2B trafﬁcking.
D1R stimulation results in an increase in Fyn colocalization with
GluN2B, which is Fyn (and not Src) dependent in the PFC (Hu
et al., 2010).
Importantly, it was recently shown that D1R and NMDAR
co-stimulation, as well as cocaine in vivo, activated Fyn and phos-
phorylated GluN2B at the Tyr1472 residue. The activation of Fyn
was G-protein dependent, but independent of cAMP production
(Pascoli et al., 2011a). The exact mechanisms governing the acti-
vation of Fyn in the striatum are, however, not fully understood.
The SFK are found in an inactive state when they are phosphory-
lated on Tyr525 (for mouse Fyn). The dephosphorylation of this
site and autophosphorylation at Tyr420 leads to a conformational
change that opens the activation loop. The inactive conforma-
tion involves a binding interaction between the Fyn SH2 and SH3
domains (for review see Salter and Kalia, 2004). Therefore, the
above-mentioned interaction of PSD-95 with the SH2 domain of
Fyn may favor Fyn activation, but whether it may be a cause or
consequence is unclear.
As for the deactivation of Fyn an interesting candidate is striatal
enriched protein tyrosine phosphatase (STEP). STEP dephospho-
rylates GluN2B at Tyr1472(Snyder et al., 2005). STEP exists in two
major catalytic isoforms STEP46 and STEP61, which have distinct
N-terminus regions, and each isoform has a speciﬁc intracellular
location. STEP46 is localized in the cytosolic compartment, while
STEP63 is attached to membranes of the ER or PSD. To interact
with its substrates, STEPs must bind them using a kinase inter-
acting motif (KIM) domain. The KIM of STEP is phosphorylated
by PKA after D1R activation, at Ser160 and Ser221 in STEP61
and Ser49 for STEP46 (Paul et al., 2000). This phosphorylation
event prevents STEP binding to its substrates. The Ser160 site is
suspected to have a role in the regulation of a proteolytic cleav-
age sequence (known as PEST sequences) in STEP,whereas Ser221
and Ser46 may lose afﬁnity for their substrates after phosphory-
lation. STEP61 KIM binds to the SH2 and N-terminus domain
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of Fyn, and dephosphorylates the Tyr420 regulatory site but not
the Tyr531 sites (Nguyen et al., 2002). STEP also dephosphorylates
the mitogen activated protein kinase (MAPK) extracellular-signal
regulated kinase (ERK; Pulido et al., 1998).
EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAY
A major consequence of drugs of abuse administration is acti-
vation of the MAP kinase/ERK (extracellular-signal regulated
kinase) pathway. ERK1 and ERK2 are two closely related mitogen-
activated protein kinases (MAP-kinases), which are activated by
phosphorylation of their activation loop byMAP-kinase and ERK-
kinase (MEK1and2).Valjent et al. (2000) demonstrated that acute
cocaine elicits a rapid and transient increase in ERK1/2 phos-
phorylation within the ventral and dorsal striatum that remained
after chronic administration. They further demonstrated that
ERK1/2 activation was a common feature of most drugs of abuse
(Valjent et al., 2001, 2004). Even if slight differences could be
observed in the kinetic patterns of activation, nicotine, mor-
phine, 9-tetrahydrocannabinol (THC) and psychostimulants,
increased ERK1/2 phosphorylation occurred in the reward cir-
cuitry, including the prefrontal cortex, the striatum (dorsal part
and NAc) as well as the extended amygdala. In all cases, and all
structures drug-induced ERK activation was blocked by the D1R
antagonist, SCH23390 (Valjent et al., 2004). 3,4-methylenedioxy-
methamphetamine (MDMA, also known as ecstasy), and ethanol
also activate ERK1/2 in the striatum (Salzmann et al., 2003; Ibba
et al., 2009). ERK1/2 activation induced by drugs of abuse is func-
tionally relevant since SL327, a pharmacological compound that
act on MEK and crosses the blood-brain barrier, prevented the
long-term behavioral effects of cocaine, such as CPP;Valjent et al.,
2000, or the development of locomotor sensitization (Valjent et al.,
2006a). A different MEK inhibitor, PD98059, injected into the
NAcc either before or after CPP training sessions blocks sub-
sequent amphetamine CPP expression (Gerdjikov et al., 2004).
ERK activation is also involved in the reconsolidation of drug-
associated memories since it was reactivated by exposure to the
drug-associated context and because MEK inhibition was able
to erase previously acquired CPP (Miller and Marshall, 2005;
Valjent et al., 2006b).
Striatal ERK2 activation involves both D1Rs and NMDA gluta-
mate receptors, since it is prevented by either a D1R antagonist or
in D1R knock-out mice, or by an NMDA antagonist (Valjent et al.,
2000, 2005). It is only observed in a subset of D1R-expressing
striatonigral neurons (Bertran-Gonzalez et al., 2008). Therefore,
the modality of ERK1/2 activation in MSNs has been proposed
to reﬂect the convergence of DA and glutamate signaling onto
MSNs, thereby placing ERK1/2 as a coincidence detector, which
detects the simultaneous arrival of contextual information coded
by corticostriatal and thalamostriatal glutamate inputs, and the
reward prediction error coded by DA neurons (Girault et al.,
2007).
Whether ERK1 or ERK2 is fully responsible for the molecu-
lar responses to cocaine remains to be established. Ablation of
ERK1 in cultured cells resulted in a stimulus-dependent increase
of ERK2 signaling (Mazzucchelli et al., 2002), without altering the
basal levels of ERK2 expression. This apparent competition of
ERK1 with ERK2 signaling, that is removed in the knock-out mice,
lends the interpretation of the independent role of each isoform
complex. However, the generation of ERK1 mutant mice revealed
that removal of ERK1 results in an hypersensitivity to the reward-
ing properties of morphine and the rewarding and psychomotor
effects of cocaine (Mazzucchelli et al., 2002; Ferguson et al., 2006).
Furthermore, increased synaptic plasticity LTPwas observed in the
NAcc, hippocampus, and lateral amygdala slices from ERK1 KO
mice, an effect that was speciﬁcally reversed by U0126, a selec-
tive MEK inhibitor (Mazzucchelli et al., 2002). These ﬁndings
strongly support that ERK2 is the dominant isoform for neu-
ronal plasticity and behavioral adaptations induced by addictive
drugs.
Upstream from MEK, ERK activation induced by cocaine
involves the calcium-activated guanine nucleotide exchange fac-
tor Ras-GRF1 (Fasano et al., 2009; Fasano and Brambilla, 2011).
Knock-out mice for Ras-GRF1 show a signiﬁcant reduction, but
not total inhibition, of cocaine-induced ERK activation, and
locomotor sensitization. On the other hand, mice that over-
expressed Ras-GRF1 were more sensitive to cocaine treatment
than wildtype counterparts (Fasano et al., 2009; Fasano and
Brambilla, 2011; Cerovic et al., 2013). Interestingly, Ras-GRF1 is
preferentially associatedwithGluN2B subunits (Krapivinsky et al.,
2003). The cross talk between D1R and NMDA receptors impli-
cates a cAMP-independent pathway that increases responsiveness
of GluN2B containing NMDA receptors to glutamate (Pascoli
et al., 2011a). In striatal neurons, D1R stimulation leads to an
increase in Ca2+ inﬂux through NMDARs via SFK/Fyn-induced
phosphorylation of the GluN2B subunit at Tyr1472. In parallel,
PKA-mediatedphosphorylationof DARPP-32promotes ERKacti-
vation through an indirect inhibition of STEP. DARPP-32 thus
prevents ERK dephosphorylation and contributes to enhanced
glutamate mediated-ERK activation (see Figure 1; Valjent et al.,
2005).
As stated above, mGluR5 receptors seem to be critically
involved in cocaine-induced long term behavioral alterations. A
link between amphetamine-induced ERK phosphorylation and
mGluR5 was found when using a mGluR5 antagonist, MPEP,
which blocked amphetamine induction of ERK in the dorsal stria-
tum (Choe et al., 2002). Surprisingly, this inhibition was not due
to mobilization of intracellular Ca2+ stores since dantrolene – a
compound that blocks intracellular Ca2+ release from ryanodine-
sensitive stores – did not affect amphetamine effects. The Group
I mGluR can modulate NMDAR signaling onto ERK activation
via PKC (Niswender and Conn, 2010) and also via direct physical
interactions (Perroy et al., 2008).
An elegantwork fromPascoli et al. (2011b) recently showed that
ERK activation was necessary for corticostriatal LTP induced by
electrical stimulation in slices of mice treated with cocaine admin-
istration in vivo, and that this synaptic plasticity was necessary
for locomotor sensitization (Pascoli et al., 2011b). Furthermore,
it is now well established that this long-term behavioral adapta-
tion to cocaine relies on gene regulation and new protein synthesis
(Valjent et al., 2006a).
Under basal conditions, the unphosphorylated form of
ERK1/2 is detected in the cytoplasm of neurons. Upon
cocaine administration, the active di-phosphorylated ERKs
translocate to the nucleus where they control both epigenetic
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FIGURE 1 | Cocaine, similarly to most drugs of abuse, produces long
lasting brain changes, that relie on gene expression and new protein
synthesis.These long-term neuronal adaptations take place in majority in
DA-D1R expressing MSNs that belong to the direct pathway. The ERK
pathway is central in this striatal plasticity, and detects a combination of
glutamate and DA signals that are essential for long lasting modiﬁcations.
Cocaine-induced ERK activation depends on complex cascade of
phosphorylation events downstream D1-R. Importantly, the triggering event
in ERK activation depends on a non-canonical signaling pathway that
associates Fyn-induced phosphorylation of GluN2B and increases in
calcium inﬂux into D1-R MSNs. The duration and maintenance of ERK
activation occurs via cAMP/PKA pathway. The cAMP/PKA pathway,
downstream D1 receptors (left panel) triggers deactivation of
phosphatases, PP1 on one hand via DARPP-32, and STEP on the other
hand (Valjent et al., 2005). By controling the activity of the tyrosine kinase
Fyn and the dual speciﬁcity protein kinase MEK, this signaling cascade
intervenes in the state of phosphorylation of ERK downstream DA-D1R
stimulation. However, we propose that triggering ERK activation depends
on a “non-canonical signaling” pathway downstream D1-R (right panel). A
cAMP-independent activation of Fyn produces tyrosine phosphorylation of
GluB2B subunit of NMDA-Rs that in turn facilitates calcium inﬂux (Pascoli
et al., 2011a), and activation of the calcium-sensitive Ras-guanine releasing
factor (Ras-GRF1) that activates the MEK/ERK pathway (Fasano and
Brambilla, 2011). Upon cocaine stimulation ERK translocates to the nucleus
where it controls epigenetic and genetic programs. Among the latter, the
transcription factor Elk-1 is a component of the ternary complex factor,
which binds to SRE (Besnard et al., 2011a). ERK1/2 also phosphorylates the
nuclear kinase MSK1which appears to play a prominent role in
phosphorylation of histone H3 and cAMP-response element-binding
(CREB) protein (Brami-Cherrier et al., 2005). This leads to the expression of
immediate-early genes, which are particularly sensitive to CREB (e.g., cFos)
or ternary complex factor (e.g., Zif268 a.k.a. Egr-1). These two nuclear
pathways downstream from ERK have distinct roles in long-term behavioral
adaptations (see text). DA-GPCR and NMDAR, in particular D1R and GluN1,
oligomerization has been documented in heterologous systems,
hippocampal, and striatal tissues after cocaine exposure. The role of
D1R-GluN1 interaction in ERK activation and downstream molecular events
remains to be established.
and genetic responses. This cyto-nuclear shuttling of ERK
involves clathrin-dependent endocytosis originating from glu-
tamate AMPA receptors (AMPAR) endocytosis (Triﬁlieff et al.,
2009).Within the nucleus ERK2 can phosphorylate several nuclear
kinases, including p90 ribosomal protein S6 kinases (RSK1/2)
and the mitogen and stress-activated protein kinases MSK1 and
2. MSK1, but not RSK1/2 nor MSK2, is rapidly phospho-
rylated downstream of ERK in MSN in response to cocaine
(Brami-Cherrier et al., 2005). In turn, activatedMSK1 targets both
the cAMP-responsive element-binding (CREB) transcription fac-
tor and histone H3 and msk1 knockout mice show a decreased
phosphorylation of Ser133-CREB and Ser10-histone H3 induced
by cocaine (Brami-Cherrier et al., 2005). This effect on Ser133-
CREB phosphorylation was particularly remarkable as this residue
is a common substrate for various kinases, including RSK1/2,
CaMKIV, and PKA,with PKA being traditionally considered as the
major CREB kinase in the striatum (Nestler, 2004). For transcrip-
tion to occur, DNA decompaction is required to allow the action
of the core transcription machinery and transcription factors.
Such remodeling of DNA depends on post-translational modi-
ﬁcations of histones, including Ser10-histone H3 phosphorylation
that positively regulates gene expression (Brami-Cherrier et al.,
2009). The default of cocaine-induced Ser10-histone H3 phos-
phorylation observed in msk1 deﬁcient mice was associated with
a striking impact on the induction of immediate early genes, such
as c-Fos and dynorphin, which were blocked, whereas the induc-
tion of Egr-1/Zif268 was spared (Brami-Cherrier et al., 2005).
Remarkably, msk1 null mice displayed a decreased psychomotor
sensitization to cocaine, whereas CPP was slightly enhanced, in
agreement with the role of CREB and dynorphin in the aversive
effects of drugs (Carlezon et al., 1998). MSK1-independent genes,
such as zif268, thus seem to be more related to the rewarding
properties of cocaine, as supported by the lack of cocaine-
induced CPP encountered in zif268 knockout mice (Valjent et al.,
2006b). Although the role of kinases in histone H3 phospho-
rylation has been extensively investigated, phosphatases are also
implicated in this process. Inhibition of PP1, the phosphatase
for Ser10-histone H3, is induced by cocaine via phosphoryla-
tion and nuclear translocation of DARPP-32 and is involved in
H3 phosphorylation in response to cocaine (Stipanovich et al.,
2008).
Ternary complex factors (TCFs) are direct ERK targets that con-
trol serum responsive element (SRE)-driven transcription. Among
TCFs, Elk1 is phosphorylated by ERK in MSN in response to
acute cocaine or amphetamine (Valjent et al., 2000; Choe et al.,
2002). The role of Elk1 in mediating cocaine responses was
difﬁcult to determine because of the redundancy within TCFs
(Cesari et al., 2004) and because Elk-1 is found in dendrites
and nuclei of neurons (Sgambato et al., 1998) where it governs
opposite biological outcomes (Besnard et al., 2011b). In MSN,
phosphorylation on Ser383/389-Elk-1 by ERK triggers its translo-
cation from the cytoplasm to the nucleus (Lavaur et al., 2007).
The selective inhibition of Elk-1 phosphorylation, downstream
ERK, using a cell penetrating peptide, the TAT-DEF-Elk-1 (TDE;
Lavaur et al., 2007), signiﬁcantly impaired cocaine-induced IEG
expression (cFos, Zif268, and Arc) along with dentritic spine
formation onto MSN (Besnard et al., 2011a). An unexpected
effect of TDE was found on chromatin remodeling since histone
H3 phosphorylation induced by cocaine was strongly impaired,
despite maintained MSK-1 phosphorylation. These data indicate
that Elk-1 phosphorylation in the nucleus orchestrates impor-
tant molecular events, including the recruitment of MSK-1 to
the DNA, close to histones. Importantly, TDE also interfered with
locomotor sensitization and CPP (in a one but not three-pairing
protocol).
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OLIGOMER FORMATION: A POTENTIAL MECHANISM FOR
D1R-MEDIATED REGULATION OF GLUTAMATE
TRANSMISSION
Interactions between DA-GPCR and NMDAR have been docu-
mented The subcellular co-localization of D1R and NMDAR has
been characterized in the striatum by electron microscopy (Hara
and Pickel, 2005). This physical proximity supported the idea that
the two receptors interact extensively. Lee et al. (2002) demon-
strated that D1R interact with the GluN1 and GluN2A subunits,
using co-immunoprecipitation studies from rat hippocampal cul-
tures and transfection of Cos-7 cell and HEK2397 lines (Pei
et al., 2004). Three GST-peptides were constructed based on the
sequence of the D1R c-terminal tail (D1-t sequences) and inter-
actions were revealed between the D1-t2 sequence and the GluN1
subunit and D1-t3 sequence and the GluN2A subunit. Subsequent
biochemical studies using synthesized peptides were able to deter-
mine, by mass spectrometry, that the interaction was likely due
to electrostatic forces (Woods et al., 2005). The GluN1-C1 cassette
contains the Arg-rich epitope and the D1R contains a correspond-
ing acidic epitope. Mass spectrometry showed that these two
regions interacted and interestingly, they found that Ser397 in the
Dt2 acidic epitope could possibly be phosphorylated by CKI and
a phosphorylated version of the peptide bound ﬁve times more to
the GluN1Arg rich epitope. It remains to be shown in more native
receptor environments if indeed this residue favors the associa-
tion. The stability of the D1-t2/GluN1 interaction after exposure
to ligand remains unclear. In hippocampal neurons and in Cos-7
cells co-transfected with D1R and GluN1, Lee et al. (2002) saw
a signiﬁcant decrease in the co-immunoprecipitation of D1R or
Glu1 after treatment with SKF-81297. However, no such changes
were seen for the D1/GluN2A interaction.
The D1R/GluN1 interaction was also found in PSD enriched
fractions of striatal tissue (Fiorentini et al., 2003). The authors
showed that co-expression of the D1R/GluN1/GluN2B subunits
allowed their trafﬁcking to the membrane. It had previously been
established that GluN1 alone is restricted to the ER and when
GluN1 was co-transfected with D1R, the D1R signal also became
restraint to the cytosol and ER. It is thought that oligomerization
may hide ER retention signals allowing the passage of the recep-
tor to the export machinery. Despite DA not affecting the BRET
signal for association, it was shown that SKF-81297 treatment pre-
vented the internalization of D1Rbut onlywhen co-expressedwith
GluN1/GluN2B. This may suggest that once at the membrane in a
formed complex, stimulation of the D1R stabilized its presence or
association. The association of D1R with NMDAR not only alters
their trafﬁcking from the ER to the plasma membrane but also
along its surface. Scott and colleagues were able to observe that
after just 3 mins from exposure to NMDA, MSN spines contained
more D1R (Scott et al., 2006). To explain how D1R signal in spines
was increased by NMDA, the authors proposed that the direct
interaction with NMDAR would “trap” the D1R to the synapse.
They performed site-directed mutagenesis experiments and found
that if Ser397 or Ser398 in the Dt2 domain were mutated to alanine
the NMDA effect was lost and the D1R no longer bound GluN1
GST-peptides. The authors were unable to conﬁrm a kinase for
these sites, yet their ﬁndings established a model, the “diffusion
trap,” whereby NMDAR activation would cause some change in
the receptor to enhance the binding with D1R and “trap” them to
the spine. The ultimate result of the above mentioned diffusion
trap would be to potentiate mutually the receptors.
The D1R/GluN1 oligomer has been demonstrated to have
consequences on cellular plasticity and behavior in the hippocam-
pus (Nai et al., 2010). The authors described that theD1Rmediated
enhancement of plasticity was via direct interactions with GluN1
that was also necessary for spatial working memory. Studies have
also addressed whether these D1R/NMDAR oligomers may be
implicated in pathologies. DA and glutamate transmission are fre-
quently considered in studies of PD, and Fiorentini et al. (2006)
found a signiﬁcant decrease in the D1R/NMDAR interaction in
both the 6-OHDA lesioned mice and in the L-DOPA induced
dyskinetic (LID) mice relative to controls.
As with regards to drugs of abuse, one study did examine
the D1R/GluN1 interaction after exposure to cocaine (Sun et al.,
2009). By Western-blotting, the authors did not detect any change
in total expression of the D1R or GluN1 in the dorsal striatum
over a 60-min period following an acute (30 mg/kg) injection of
cocaine. The authors reported that at 30 min post-acute cocaine
there was a signiﬁcant decrease in the GluN1 immunoprecipitated
by theD1R antibody. The authors speculated that as the time point
where they saw their effect corresponds to the point at which ERK
activity returns to basal activity, the two may be linked and that the
disruption of the D1R/GluR1 interaction may limit ERK activity.
These possibilities were not tested and so remain to be investi-
gated. A D2R/GluN2B oligomer was also found to be regulated by
cocaine (Liu et al., 2006). In the striatum the association between
the third intracellular loop of the D2R and the carboxyl terminal
tail of GluN2B was enhanced by cocaine. The binding of D2R to
the GluN2B displaces CaMKII and reduced GluN2B phosphoryla-
tion at Ser1303and calcium currents. Furthermore this interaction
was shown to have functional consequences as a TAT-coupled pep-
tide that mimicked the D2R region of interaction prevented acute
horizontal activity and stereotyped behavior normally induced by
cocaine. These studies suggest that direct interactions between
DA GPCR and NMDAR will provide another level for interaction,
and perhaps possible interventions, with regards to addictive-drug
induced signaling.
CONCLUSION PERSPECTIVES
Despite the usefulness of animal models for studies of addic-
tion treatment the majority of therapeutic strategies for cocaine
addiction still consist mostly of psychiatric therapy. For psychos-
timulants in general, there is a marked absence of effective treat-
ments despite considerable neurobiological knowledge. Unlike
some other “addictions” substitution regimes do not exist for
cocaine. Most strategies are based on targeting the neurotrans-
mitter receptors implicated in the reward circuitry. Dissimilar to
alcohol or opiates, the withdrawal syndrome from cocaine is not
as severe and thus, therapies can focus more on preventing relapse
and craving rather than treating withdrawal symptoms.
As DA plays a critical role in motivation, reward, and locomo-
tion, studies have focused on modifying its functions in addicted
humans. To counter the DA increase elicited by cocaine, a DA
depletor reserpinewas tested in humans but found to be ineffective
(Winhusen et al., 2007). A D1R antagonist Ecopipam was tested
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in humans who were addicted to crack cocaine, and was found
to reduce self-assessed measures of acute cocaine effects such as
the “high” (Romach et al., 1999). However, with chronic admin-
istration Ecopipam unfortunately failed as it actually increased
the reported “high” of the drug and increased self-administration
(Haney et al., 2001). An explication for these ﬁndings is that the
levels of expression and D1R sensitivity may be upregulated after
chronic antagonism. Targeting solely DA transmission therefore
has many caveats, in addition agonists or indeed antagonists may
have non-speciﬁc effects on other DA regulated functions such as
body temperature or cardiovascular function and the antagonists
may alter mood and lead to non-compliance.
The glutamatergic system is also implicated in cocaine addic-
tion and therapeutic studies have turned to drugs, which should
balance glutamate transmission. Unfortunately few studies have
shown any promise in humans. The non-competitive glutamate
receptor antagonists Amantadine and Memantine (acting on the
NMDAR) did not aid addicts to abstain from cocaine (Kampman
et al., 2006; Collins et al., 2007). Although promising in rodent
cocaine studies and successful for human alcohol dependence,
the drug Acamprosate (NMDA type Glu receptor antagonist and
GABAa receptor agonist), proved ineffective for human cocaine
addicts (Kampman et al., 2011). Some success was had with N-
acetylcysteine, which promotes the replacement of intracellular
glutamate for cysteine via anti-porters and so reduced gluta-
mate transmission. In a pilot study, it was found to diminish
the taking of cocaine by the majority of patients after treat-
ment in the study (Mardikian et al., 2007). This may encourage
future studies aiming to tone down Glu transmission in cocaine
addiction.
Furthermore, in the early 1990s, a cocaine vaccine was devel-
oped. It was believed that the production of antibodies against the
cocaine molecules could block its effects and thus help maintain
abstinence. Unfortunately, getting patients to produce efﬁcient
levels of antibodies proved to be a great limit to this approach.
A vaccine is currently under phase II multi-site clinical trials, but
some reservations have been voiced regarding ethics of vaccines
against addiction being used as an prevention or as a treatment
(Young et al., 2012).
In summary, a considerable number of human and pre-clinical
animal studies focus on restoring perturbations in the balance of
DA and Glu transmission as a therapy for cocaine addiction, but
from animal studies we nowknow that ERK signaling is a key coor-
dinator in this system. We propose that D1R/GluN1 oligomers
could participate also in this synergy. While blocking ERK acti-
vation by drugs is validated in animal models, its potential for
human treatment is limited as it is a kinase implicated in a wide
range of cellular processes. Instead, we content that targeting ERK
signaling and its downstream partners (MSK-1 and histone phos-
phorylation, Elk-1 phosporylation) within D1R-MSN speciﬁcally
is a promising strategy. This strategy could include the signaling
events that are at the crossroad of D1R and NMDAR synergism in
response to cocaine (see Figure 1).
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